LUIS MIGUEL RUILOPE URIOSTE-rekin lankidetzan egindako argitalpenak (7)

2023

  1. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE

    Journal of hypertension, Vol. 40, pp. e81

2017

  1. Rapid, automated, and specific immunoassay to directly measure matrix metalloproteinase-9-tissue inhibitor of metalloproteinase-1 interactions in human plasma using AlphaLISA technology: A new alternative to classical ELISA

    Frontiers in Immunology, Vol. 8, Núm. JUL

2014

  1. Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression

    Journal of Hypertension, Vol. 32, Núm. 10, pp. 2082-2091

  2. One step forward for serelaxin as a promising therapy in cardiac fibrosis

    Hypertension

2001

  1. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.

    Hypertension, Vol. 37, Núm. 5